<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mechanisms underlying the development of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> are poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>To discover the role of <z:mp ids='MP_0003674'>oxidative stress</z:mp> and radical scavenger capacity in the <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, we measured myeloperoxidase activity, <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase activity, <z:chebi fb="0" ids="16856">glutathione</z:chebi> content and total aromatic DNA adducts </plain></SENT>
<SENT sid="2" pm="."><plain>Mucosal specimens came from 52 patients in 6 groups: symptomatic <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> (GORD) without and with endoscopic <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e>, Barrett's epithelium without and with <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the oesophagus and controls </plain></SENT>
<SENT sid="3" pm="."><plain>In the GORD-<z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e>-<z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence, <z:chebi fb="0" ids="16856">glutathione</z:chebi> content was progressively lower and myeloperoxidase activity higher than in controls, plateauing at Barrett's epithelium without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Only in Barrett's epithelium with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was SOD activity significantly increased </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patient groups, DNA adduct levels were significantly higher than the control level </plain></SENT>
<SENT sid="6" pm="."><plain>Though these levels between patient groups did not differ significantly, the level was highest in Barrett's epithelium without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and progressively lower in Barrett's with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Pooled data showed a negative correlation between <z:chebi fb="0" ids="16856">glutathione</z:chebi> content and DNA adducts (-0.28, p = 0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Simultaneous formation of DNA adducts, increased myeloperoxidase-related <z:mp ids='MP_0003674'>oxidative stress</z:mp>, decreased <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity (<z:chebi fb="0" ids="16856">glutathione</z:chebi> content) and the negative correlation between <z:chebi fb="0" ids="16856">glutathione</z:chebi> content and DNA adducts in the GORD-<z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e>-<z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> indicate a role in the pathogenesis and <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> related to <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
</text></document>